Philadelphia-positive mixed phenotype acute leukemia presenting with PML-RARa fusion transcript without t(15;17) on cytogenetic studies

Chemotherapy Adherence Is a Favorable Prognostic Factor for Elderly Patients With Multiple Myeloma Who Are Treated With a Frontline Bortezomib-Containing Regimen

Platelet to lymphocyte ratio (PLR) retains independent prognostic significance in advanced stage marginal zone lymphoma patients treated with rituximab, cyclophosphamide, vincristine, and prednisone combination chemotherapy (R-CVP): Consortium for Improving Survival of Lymphoma trial

Clinicopathologic significance of tumor microenvironment CD11c, and FOXP3 expression in diffuse large B-cell lymphoma patients receiving rituximab, cyclophosphamide, anthracycline, vincristine, and prednisone (R-CHOP) combination chemotherapy

Clinical Significance of Peroxisome Proliferator-Activated Receptor gamma and TRAP220 in Patients with Operable Colorectal Cancer

Malignant Adenomyoepithelioma of the Breast and Responsiveness to Eribulin

Analysis of factors affecting hemorrhagic diathesis and overall survival in patients with acute promyelocytic leukemia

The prognostic impact of inflammatory factors in patients with multiple myeloma treated with thalidomide in Korea

불응성/재발성 다발골수종의 볼테조밉 구제 치료의 실제: 단일 기관의 경험

DNA Ligase4 as a Prognostic Marker in Nasopharyngeal Cancer Patients Treated with Radiotherapy